Center for Molecular Nutrition and Sensory Disorders, The Taste and Smell Clinic, 5125 MacArthur Blvd, NW, Suite 20, Washington, DC 20016, USA.
Department of Neurology, The George Washington University Medical Center, 2150 Pennsylvania Avenue, NW, 7th Floor, Washington, DC 20037, USA.
Brain Sci. 2013 Nov 15;3(4):1483-553. doi: 10.3390/brainsci3041483.
Olfactory hallucinations without subsequent myoclonic activity have not been well characterized or understood. Herein we describe, in a retrospective study, two major forms of olfactory hallucinations labeled phantosmias: one, unirhinal, the other, birhinal. To describe these disorders we performed several procedures to elucidate similarities and differences between these processes. From 1272, patients evaluated for taste and smell dysfunction at The Taste and Smell Clinic, Washington, DC with clinical history, neurological and otolaryngological examinations, evaluations of taste and smell function, EEG and neuroradiological studies 40 exhibited cyclic unirhinal phantosmia (CUP) usually without hyposmia whereas 88 exhibited non-cyclic birhinal phantosmia with associated symptomology (BPAS) with hyposmia. Patients with CUP developed phantosmia spontaneously or after laughing, coughing or shouting initially with spontaneous inhibition and subsequently with Valsalva maneuvers, sleep or nasal water inhalation; they had frequent EEG changes usually ipsilateral sharp waves. Patients with BPAS developed phantosmia secondary to several clinical events usually after hyposmia onset with few EEG changes; their phantosmia could not be initiated or inhibited by any physiological maneuver. CUP is uncommonly encountered and represents a newly defined clinical syndrome. BPAS is commonly encountered, has been observed previously but has not been clearly defined. Mechanisms responsible for phantosmia in each group were related to decreased gamma-aminobutyric acid (GABA) activity in specific brain regions. Treatment which activated brain GABA inhibited phantosmia in both groups.
嗅觉幻觉而无随后的肌阵挛活动尚未得到很好的描述或理解。在此,我们在回顾性研究中描述了两种主要形式的嗅觉幻觉,称为幻嗅:一种是单侧的,另一种是双侧的。为了描述这些障碍,我们进行了几项程序来阐明这些过程之间的相似之处和差异。从 1272 年开始,在华盛顿特区的味觉和嗅觉诊所评估味觉和嗅觉功能障碍的 1272 名患者,进行了临床病史、神经学和耳鼻喉科检查、味觉和嗅觉功能评估、EEG 和神经影像学研究,其中 40 名患者表现为周期性单侧幻嗅(CUP),通常无嗅觉减退,而 88 名患者表现为非周期性双侧幻嗅伴有相关症状(BPAS),伴有嗅觉减退。CUP 患者自发或在大笑、咳嗽或大喊后出现幻嗅,最初自发抑制,随后进行瓦尔萨尔瓦动作、睡眠或鼻水吸入;他们经常出现 EEG 变化,通常为同侧尖波。BPAS 患者在几种临床事件后出现幻嗅,通常在嗅觉减退后出现,且 EEG 变化较少;他们的幻嗅不能通过任何生理动作引发或抑制。CUP 很少见,代表一种新定义的临床综合征。BPAS 很常见,以前也观察到过,但尚未明确界定。两组幻嗅的机制与特定脑区 GABA 活性降低有关。激活大脑 GABA 的治疗抑制了两组患者的幻嗅。